Panel experts voiced their support for allowing drug and health care companies to access the power of social networks during the Food and Drug Law Institute’s recent Advertising and Promotion Conference in Washington, D.C.
These experts discussed how to communicate the message of drug and health care product safety and risk to the public as they wait for the Food and Drug Administration to set guidelines online pharmacy without prescription on how health care companies and marketers can proceed into the social-media space — regulation that are expected by the end of the year.
“The right patient, the right medication, at the right time, should be our goal,” said panelist Freda Lewis-Hall, the chief medical officer and a senior vice president at Pfizer. “We have narrowing opportunities to provide the best informed, most accurate information about our products.”
The problem, Lewis-Hall said, is staying within strict marketing rules set forth by the FDA, while advice from patients, practicioners and anonymous bloggers goes unchecked.
“We know people don’t know how to vet information available to them in cyberspace,” she said. “But the fact remains that we’re not the trusted source of information.”
Read the full post at SmartBlog on Social Media